Compounds as inhibitors of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
本研究提供了作为活化转录因子 6(
ATF6)
抑制剂的化合物。这些化合物可作为治疗剂用于治疗由
ATF6 介导的疾病或紊乱,尤其可用于治疗病毒感染、神经退行性疾病、血管疾病或癌症。